visceral leishmaniasis
GalChimia in RSC Med. Chem. – Drug Discovery for the Treatment of Visceral Leishmaniasis
August 20, 2020

Check out our new paper about the identification of 6-amino-1H-pyrazolo[3,4-d]pyrimidines with in vivo efficacy against visceral leishmaniasis

Read More
Napropamide impurities and metabolites: a complementary approach using chemical synthesis and biosynthesis
White Paper – Napropamide impurities and metabolites
July 22, 2020

We are excited to present the work carried out in collaboration with Hypha Discovery for the preparation of a wide range of napropamide derivatives with great interest to the agrochemical industry.

Read More
BIOGREEN results
Results of the BIOGREEN project
February 4, 2020

GalChimia thanks all the members and collaborators of the project BIOGREEN for their involvement and work, which have been key to obtaining the present results.

Read More
Avances del proyecto IO4COLON
October 15, 2019

El pasado viernes (11 de octubre 2019) se celebró la jornada de seguimiento del proyecto IO4COLON para el descubrimiento de productos terapéuticos novedosos contra el cáncer de colon.

Read More
Jornada de seguimiento del proyecto IO4COLON
October 3, 2019

GalChimia se complace en invitaros a la jornada de seguimiento del proyecto IO4COLON

Read More
GalChimia Team
Advances in the development of antileishmanial treatments
May 28, 2019

Our team in Madrid was involved in the development of antileishmanial compounds. This research was made in collaboration with GSK and Dundee University.

Read More
nanofacturing results
Results of the Nanofacturing project
April 16, 2019

GalChimia thanks all the partners of the Nanofacturing project for the involvement and teamwork that have been key to obtaining the results.

Read More
Droughtdrugs Project, discovery of agrochemicals to improve drought tolerance in crop plants
February 26, 2019

The main objective of the Droughtdrugs Project is to develop a new generation of compounds that can activate drought tolerance in crop plants.

Read More
GalChimia, Oncostellae y AMSlab presentan el proyecto IO4COLON
February 25, 2019

IO4COLON es una iniciativa de investigación liderada por GalChimia, Oncostellae y AMSlab para el descubrimiento de nuevos fármacos contra el cáncer de colon

Read More
GalChimia is happy to be part of a collaborative effort to boost EU Synthetic Biology competitiveness
January 17, 2019

An 8 million Euros grant was attributed by the EU to the ShikiFactory100 project, an international effort coordinated by biotech SME SilicoLife, in cooperation with some of the most relevant players in Europe, covering leading research institutions, SMEs and a large industrial company.

Read More